Start free
Workflows

Pharma partnering

Know which pharma to approach, and with what: Sleuth maps the top 25 pharma’s pipelines by franchise, matches your best program to where each one is thin, and lists the proof each will ask for.

Run Pharma partnering

In Studio: Platform to Pharma Partnering

Use it when

  • You're a platform biotech's CEO or BD lead preparing for a partnering conference or a round of outreach.
  • You want to tailor each pitch to what that pharma is building, instead of sending one deck to everyone.
  • You need to prepare for one big meeting with the objections and proof in hand.

What to have ready

What your platform has and hasn't shown, the decision you face, such as a conference coming up, and where you want to focus. It works before you have clinical data.

How it runs

  1. Describe your platform. Its data so far and the areas you want to focus on.
  2. Decide what counts. Choose what makes a good partner for you, such as fit with a franchise, deal record, and whether it already owns a competing platform, and how much each one counts.
  3. Shape the plan. Sleuth shows its three steps: map the pipelines, match your programs and rank the pharma, and prepare each outreach. Add a company or drop one before it runs.
  4. Get the analysis. A ranked list of pharma, with what to lead with and what to bring for each, and the program matches as a dataset.

What you get

Your questionWhat Sleuth gives you
What is each pharma building?Each pharma's programs, deals, and stated priorities, franchise by franchise, with the platforms it already owns or licenses.
Where does our platform fit them?What your platform could lead with, matched to each franchise and ranked on cited evidence. Sleuth sets aside any fit that depends on data you don't have yet.
Who already has something like us?The pharma that own or license a competing platform, ranked lower with the reason, so you don't pitch a company that's building it in house.
What will each one ask before a meeting?For each priority pharma, the case for and against, the objections to expect, the proof to have in hand, and the events to watch before your meeting.

A finished example

Which pharma should an immune-cell RNA platform approach first? Sleuth says Biogen. A fictional platform, matched to the top 25 pharma before a March partnering conference. Given the same question, a general AI model left Biogen out. See the full example

Questions

Does it work before we have clinical data?

Yes. The example platform is preclinical. Sleuth sets aside any fit that depends on data you don't have yet, and lists the proof to get first.

Can I add a pharma that isn't in the top 25?

Yes. Add it when you shape the plan, and Sleuth maps it the same way.

Can I prepare for one meeting instead of five?

Yes. Name the company, and Sleuth builds its case for and against, the objections to expect, and the proof to bring.

How does Sleuth know what each pharma wants?

From each pharma's programs, deals, and stated priorities, read franchise by franchise, with the source behind each one.

Why is a pharma ranked lower?

Sleuth gives the reason beside it, such as owning a competing platform, or a fit that depends on data you don't have yet.

Credits

The plan shows the size of the job before anything runs: rows times analytical columns is the credits it will use. How credits work

Next questions on the same project

Indication selection settles what to lead with. Standard of care evolution shows the market a partner will weigh. Monitoring keeps each pharma's pipeline current before the meeting.